About this product

This Live Swine Erysipelas Vaccine (Strain GC42) is a biological product designed for the prevention of swine erysipelas, a significant bacterial disease affecting hog populations. Utilizing the specific Strain GC42, this vaccine stimulates a robust immune response in pigs, offering crucial protection against infection and its associated economic losses. While specific technical specifications and performance characteristics are best discussed directly with the manufacturer, the live nature of the vaccine implies a need for proper cold chain management and administration protocols to ensure optimal efficacy. The vaccine is formulated using high-quality biological components, ensuring its stability and effectiveness when handled and stored correctly. Available in various sizes suitable for different herd management needs, this product is ideal for importers, wholesalers, and large-scale farming operations seeking to safeguard their livestock. Its primary application lies within the swine farming industry, protecting animals from the debilitating effects of erysipelas, thereby improving herd health and productivity. This vaccine is a vital tool for businesses committed to maintaining disease-free operations and meeting international standards for animal welfare and food safety. Its suitability for international trade buyers stems from its role in disease prevention, a universal concern for global pork production, and the potential for bulk procurement to meet the demands of diverse markets.